Welcome to LookChem.com Sign In|Join Free

CAS

  • or

64334-95-8

Post Buying Request

64334-95-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

64334-95-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 64334-95-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,3,3 and 4 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 64334-95:
(7*6)+(6*4)+(5*3)+(4*3)+(3*4)+(2*9)+(1*5)=128
128 % 10 = 8
So 64334-95-8 is a valid CAS Registry Number.

64334-95-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-methyl-7-nitro-1H-quinolin-4-one

1.2 Other means of identification

Product number -
Other names 2-methyl-7-nitro-4-quinolone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:64334-95-8 SDS

64334-95-8Relevant articles and documents

Synthesis and pharmacological evaluation of new cysLT1 receptor antagonists

Griera,Armengol,Reyes,Alvarez,Palomer,Cabre,Pascual,Garcia,Mauleon

, p. 547 - 570 (1997)

This paper describes the synthesis and pharmacological evaluation of three series of compounds 4a-b, 13a-k and 19, structurally related to the known potent cysLT1 receptor antagonists RG-12553, IC1-204219 and ONO-1078, respectively. The common structural feature of these new series is the presence of a 4-quinolone nucleus acting as a template for substitution of the aromatic nucleus present in the prototype antagonists. We describe the evolution of these series leading to antagonists with potency at nanomolar concentrations in vitro.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 64334-95-8